DSS is a Billion Dollar Company in the making thanks to Mr.

New Post Public Reply Private Reply Replies (1) Message Board
RDY2ROCK
702
DSS is a Billion Dollar Company in the making thanks to Mr. Chan! Who is licensing $SFOR IP via Channel Partner ACS.
https://www.advancedcybersecurity.com/

5 MAR 19
https://www.globenewswire.com/news-release/20...ement.html
Document Security Systems, Inc. Signs Exclusive Master Distributor Agreement
DSS will sell ACS EndpointLockV™ Keystroke Encryption Software in 13 countries

Overall great read and here's a couple of key points:
DSS believes EndpointLockV is the missing link for credential and data protection,” said Mr. Fai H. Chan, CEO of DSS International.

SIZING UP THE MARKET
In the exclusive Asia and Australia market, DSS will be reaching nearly 2 billion people , including China and Hong Kong, which houses over 1.4 billion people alone and spends almost 25% more on cyber security than the global average.

In a recent 2019 cyber report published by The Herjavec Group , researchers predict global spending on cyber security products to exceed $1 trillion cumulatively over the five-year period from 2017 to 2021.

CYBERCRIME COSTS HAVE REACHED PANDEMIC PROPORTIONS
According to the Herjavec report, “ cybercrime will cost the world in excess of $6 trillion annually by 2021 , up from $3 trillion in 2015.” So far, this prediction has turned out to be accurate . The report states, “It’s about the growing number of human and digital targets. Our entire society, the Planet Earth, is connecting up to the Internet – people, places, and things. The rate of Internet connection is outpacing our ability to properly secure it. The world will need to cyber protect 300 billion passwords globally by 2020. ”


So....what about Blockchain and possible deal with our sub-BST!
https://www.blocksafetech.com/

DSS 30 MAY 19 :
https://www.globenewswire.com/news-release/20...nsion.html
DSS, a leader in anti-counterfeit, authentication, and diversion protection technologies, announced today its intention to form four new, wholly-owned subsidiaries that will participate in the growth of new and advancing global technologies and markets.

The new companies will be led by DSS board chairman Mr. Fai H. Chan, who will assume the role of Executive Chairman of each entity:
DSS Blockchain Security, Inc.
Decentralize Sharing Systems, Inc.
DSS Securities, Inc.
DSS BioHealth Security, Inc.

DSS 18 JUL 19 :
http://irdirect.net/prviewer/release/id/3925962
DSS Releases Blockchain Tracking and Authentication Technology “Sentinel” to Combat Unauthorized Sellers, MAP Violators and Retail Arbitrage within Amazon Marketplace.

The Sentinel application will be supported by the Company’s blockchain-as-a-service technology AuthentiChain™

https://www.marketdefense.com/
Complete Brand Protection - MD and Amazon.

AuthentiChain™ Link goes here to a 18 MAR 19 PR and 13 days after the DSS/ACS PR :
http://irdirect.net/prviewer/release/id/3001960

$SFOR delivered the foreign character capability by AUG 2019! So just maybe Q3 will be even better and not about the same as Q2. I have a very good feeling Q4 numbers will be really good!

ENTIRE CYBER ECOSYSTEM and COMPLIANCE!!!! ENTIRE CYBER ECOSYSTEM and COMPLIANCE!!!! ENTIRE CYBER ECOSYSTEM and COMPLIANCE!!!!

All the best,
R2R

Zerify Inc (ZRFY) Stock Research Links

ZRFY Board Company Profile Buy Rating Time & Sales News Filings Financials
$SFOR/SFT and BSAFE/BST STRONG!!!!

Parent: https://www.strikeforcetech.com

Subsidiary: https://www.blocksafetech.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 255

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 176

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 59

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading